Thursday, December 4, 2008 - 3:45PM EST

Review Articles

71. Recognition and management of neuropsychiatric complications in Parkinson's disease.

Author
Ferreri F; Agbokou C; Gauthier S;
Institution
Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, Douglas Hospital, Verdun, Quebec, Canada.
Journal
CMAJ. 2006 Dec 5;175(12):1545-52.
Abstract URL
Click here to view abstract

72. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.

Author
Moro E; Lang AE;
Institution
University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada. elena.moro@uhn.on.ca
Journal
Expert Rev Neurother. 2006 Nov;6(11):1695-705.
Abstract URL
Click here to view abstract

73. Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.

Author
Hauser RA;
Institution
Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, University of South Florida, Tampa, FL, USA.
Journal
Geriatrics. 2006 Sep;61(9):14-20.
Abstract URL
Click here to view abstract

74. Neuroprotective therapy in Parkinson disease.

Author
Chen S; Le W;
Institution
Institute of Neurology, Ruijin Hospital, Shanghai 2nd Medical University, Shanghai, China.
Journal
Am J Ther. 2006 Sep-Oct;13(5):445-57.
Abstract URL
Click here to view abstract

75. Emerging drugs for Parkinson's disease.

Author
Morgan JC; Sethi KD; Morgan JC; Sethi KD;
Institution
Medical College of Georgia, Movement Disorders Program, Department of Neurology, 1429 Harper Street, HF-1121, Augusta, GA 30912, USA. jmorgan@mcg.edu
Journal
Expert Opin Emerg Drugs. 2006 Sep;11(3):403-17.
Abstract URL
Click here to view abstract

76. Excessive daytime sleepiness and unintended sleep in Parkinson's disease.

Author
Rye DB;
Institution
Department of Neurology, Emory University School of Medicine, 101 Woodruff Circle, WMRB-Suite 6000, PO Drawer V, Atlanta, GA 30322, USA. drye@emory.edu
Journal
Curr Neurol Neurosci Rep. 2006 Mar;6(2):169-76.
Abstract URL
Click here to view abstract

77. Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.

Author
Zareba G;
Institution
Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642, USA. grazyna_zareba@urmc.rochester.edu
Journal
Drugs Today (Barc). 2006 Jan;42(1):21-8.
Abstract URL
Click here to view abstract

78. Non-motor symptoms of Parkinson's disease: diagnosis and management.

Author
Chaudhuri KR; Healy DG; Schapira AH;
Institution
Movement Disorders Unit, Kings College Hospital, Guy's King's and St Thomas' School of Medicine, London, UK. ray.chaudhuri@uhl.nhs.uk
Journal
Lancet Neurol. 2006 Mar;5(3):235-45.
Abstract URL
Click here to view abstract

79. Neural stimulation for Parkinson's disease: current therapies and future directions.

Author
Neimat JS; Hamani C; Lozano AM;
Institution
Toronto Western Hospital, Toronto, Ontario M5T 2S8, Canada. jneimat@gmail.com
Journal
Expert Rev Neurother. 2006 Jan;6(1):101-9.
Abstract URL
Click here to view abstract

80. Parkinson's disease management strategies.

Author
Rajput A; Rajput AH;
Institution
Royal University Hospital, Saskatchewan, S7N 0W8, Canada. rajputa@sask.usask.ca
Journal
Expert Rev Neurother. 2006 Jan;6(1):91-9.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10